ArticleEJNMMI research2022
Value of [
Article in EJNMMI research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 20 citations in OpenAlex.
- Article
- Role ofJournal of clinical medicine · 2025Article
- Accuracy of DOTATATE-positron emission tomography for preoperative nodal staging of carcinoid tumors of the lung.JTCVS open · 2025Article
- Updates on Pulmonary Neuroendocrine Carcinoids: Progress and Perspectives.Journal of clinical medicine · 2025Review
- Positron emission tomography in the diagnosis and management of primary pediatric lung tumors.Pediatric radiology · 2024Review
- Diagnostic accuracy of SSR-PET/CT compared to histopathology in the identification of liver metastases from well-differentiated neuroendocrine tumors.Cancer imaging : the official publication of the International Cancer Imaging Society · 2023Article
- DOTATOC PET/CT imaging of a typical carcinoid tumor in a human ex-vivo perfused lung lobe.Quantitative imaging in medicine and surgery · 2023Article
- A Systematic Review on Combined [Journal of clinical medicine · 2023Review
- Occupational radiation exposure assessment during the management of [EJNMMI physics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough most guidelines suggest performing a positron emission tomography/computed tomography (PET/CT) with somatostatin receptor (SSTR) ligands for staging of pulmonary carcinoid tumours (PC), only a limited number of studies have evaluated the role of this imaging tool in this specific patient population. The preoperative differentiation between typical carcinoid (TC) and atypical carcinoid (AC) and the extent of dissemination (N/M status) are crucial factors for treatment allocation and prognosis of these patients. Therefore, we performed a pathology-based retrospective analysis of the value of SSTR PET/CT in tumour grading and detection of nodal and metastatic involvement of PC and compared this with the previous literature and with [
methodsSSTR PET/CT scans performed between January 2007 and May 2020 in the context of PC were included. If available, [
resultsA total of 86 SSTR PET/CT scans performed in 86 patients with PC were retrospectively analysed. [
conclusionOur findings confirm the higher SSTR ligand uptake in TC compared to AC and vice versa for [
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.